D. BENJAMIN BORSON, M.A.,
J.D., Ph.D.
CURRICULUM VITAE
March 30, 2015
DISCLAIMER
The information contained in this Curriculum Vitae is for informational
purposes only, and does not imply or guarantee that any future or current legal
representation will produce similar results.
EXECUTIVE
EXPERIENCE
Founder and President, Borson Law Group, PC, Intellectual Property
Law Practice
Adjunct Professor of Law,
Past Member, Patent Public Advisory Committee,
USPTO
Board Member and Past Chair, Business Law Corporate Counsel Section,
Contra Costa County Bar
Association
Chair, Legislation Interest Group, IP Law Section, State Bar of
California
Co-Chair, Patent Policy Subcommittee, AIPLA
Co-Chair, Patent Law Subcommittee on Patentability,
AIPLA
President and Board Member, Amphion Music
Club
Past Member, New Zealand Biotechnology
Organization
Past member of the Executive Committee, Intellectual Property Law
Section, State Bar of California;
member of IP and International Law Sections
Past Co-Chair, Council of State Bar Sections
Founder and Past President, BioScience
Forum
Past Chair, Northern California Pharmaceutical Discussion
Group
Past Principal Investigator, NIH Grant-Funded research program in
basic biomedical
research
Past President, Buchanan Flying Club
Past President, Bay Flute Club
LEGAL EXPERIENCE
Intellectual Property. Develop
and implement business-focused
Scientific Consultation: Experimental design and implementation; evaluation of
methods and results. Medical
therapy and therapeutic standards in physiology, pharmaceuticals, molecular
diagnostics and genetic markers of disease
Patent Drafting: Drafting and filing provisional and utility patent
applications, PCT and non-PCT foreign patent applications. Drafting patents
relating to therapeutics including antisense, immunology, analytical methods,
pharmaceuticals, bioinformatics, chemicals, medical devices, medical and
semiconductor polymers, manufacturing processes, methods of use, semiconductor
processing equipment for polymer deposition and manufacture, organic and
inorganic chemistry, superconductors, information technology and software,
oncogenes, nucleic acids, oncogene products; methods of use: immunoassays,
antisense and antibody therapy, diagnostic methods, mechanical inventions,
consolidation of applications and claim drafting.
Patent Prosecution:
Biotechnology, chemical, pharmaceutical, bioinformatics, software,
medical device, immunological, mechanical, superconductivity and semiconductor
patent prosecution: drafting amendments relating to cellular uptake, efficacy of
antisense nucleotide therapeutics, bio-polymer chemistry, semiconductors,
medical chemistry. Preparation of
Information Disclosure Statements.
Drafting declarations and petitions supporting patentability. Drafting
Opposition documents for foreign prosecution. Consultation with foreign associates.
Over 100 patents issued
Legal Opinions:
Research and preparation of legal opinions regarding joint ventures,
non-infringement and invalidity; due diligence analysis of patent applications,
patents and patent portfolios.
Contracts and Licensing: Negotiate and draft purchase and resale agreements,
confidentiality agreements, employee agreements, consulting agreements,
technology transfer and licensing agreements. Evaluation of technical and legal
services and due diligence. Over 50
Licenses and Agreements and 12 validity or non-infringement opinions
prepared.
Trademarks:
Drafting, prosecution, and maintenance of trademark and service mark
applications and registrations in
Dispute Resolution: Legal research and analysis, preparing motions and
memoranda of points and authorities, filing court documents, court appearances,
mediation and arbitration; draft cease and desist letters.
Client Development: Develop life sciences and high-technology
practice. Meet with prospective
clients, discuss intellectual property strategies and services, develop and
implement intellectual property strategies. Portfolio of current clients includes
immunology, bioinformatics, oncology, superconductors, pharmaceuticals,
diagnostics, phototherapy, molecular diagnostics and assay development.
Public Service:
Develop and present lectures on Legal, Business and Scientific matters for
Training Associates and Staff Supervise
attorneys. staff and interns in drafting and prosecution of patent applications,
trademarks and trade secrets world-wide, patentability and infringement
opinions, firm practices and USPTO practices.
REPRESENTATIVE
CLIENTS
Company
Technology
Quantum Polymer Corporation
Chemistry, Nanotechnology and Advanced Materials
Canon USA, Inc.
Advanced Materials, Semiconductor Manufacturing and
Tools Design
Advanced Technology &
Materials, Inc.
Chemistry, Nanotechnology, Advanced Materials and
Semiconductor Manufacturing
Array Bioscience Corporation
Chemistry, Nanotechnology and Instrumentation
Neuren Pharmaceuticals
Limited
Biotechnology, Chemistry and Pharmaceuticals
Perseis
Ltd.
Antibody Therapeutics and Diagnostics
Pacific Edge Ltd.
Genetic Markers, Testing, Diagnostics, and
Bioinformatics
PrognosDx
Molecular Diagnosis and Prognosis
Biophysica,
Inc.
Organic Chemistry and Pharmaceuticals
Alpha Golf, Inc.
Medical Devices, Systems Engineering and
Therapeutics
Photomed
Technologies, Inc.
Medical Devices and Therapeutics
Fisher and Associates
Medical Diagnosis and Treatment
Otago
Innovation Ltd.
Molecular Biology, Pharmaceuticals
Immune Solutions Ltd.
Vaccines
MSM Protein Technologies
Immunology, Antibody Therapeutics
DNP Pharmaceuticals
Biotechnology and Nucleic Acid Therapeutics
Cellular Technology Limited
Biotechnology and Diagnostic Instrumentation
FzioMed
Inc.
Biotechnology; Medical Devices
Advanced Microdevices
Semiconductor Manufacturing and Chemistry
Simpson Strong-Tie Company
Construction
True Light Technologies, Inc.
Audiovisual Software
Salesforce.com
Information Technology
EMPLOYMENT IN THE
LAW
2014
Member, Committee on Professional
Responsibility and Conduct, State Bar of California.
2010-
Adjunct Professor of Law, Golden
Gate University School of Law
2009-2012
Member, Patent Public Advisory
Committee, United States Patent and Trademark Office
2006-
Founder and President, Borson Law Group, PC
2004 - 2006
Of Counsel: Fliesler Meyer LLP
(formerly Fliesler, Dubb, Meyer & Lovejoy LLP)
2003
Of Counsel: Fliesler, Dubb, Meyer &
Lovejoy LLP
1997 - 2003
Associate: Fliesler, Dubb, Meyer &
Lovejoy LLP:
1996 - 1997
Law Offices of Leona L. Lauder: Biotechnology patent prosecution
1996
Philip A. Dalton & Associates: Mechanical patent
preparation
1994
Lecturer: Uses of
DNA Technology in Forensic Sciences.
Polymerase chain reaction,
restriction fragment length polymorphism, statistical
analysis.
1993
Flehr, Hohbach, Test, Albritton, &
Herbert,
Summer Associate:
Biotechnology patent
prosecution: drafting amendments
pertaining to nucleic acids and proteins; methods of use including antisense
therapy, diagnostic methods including immunoassays.
Litigation
support: legal research and drafting:
joinder, infringement, licensing. Patent portfolio evaluation. Gene therapy, nucleic acid
delivery.
Scientific
consultation protein synthesis,
cellular uptake of therapeutic agents.
1987 - 1992
University of
Experimental
design: implementation of scientific
support for patent applications.
Biotechnology patent prosecution: drafting disclosure
documents and patent applications, declarations, and amendments relating
to Therapeutic Uses and Composition and Matter of Enkephalinase.
LEGAL
CERTIFICATION
State Bar of
Registered to Practice before the
EDUCATION
University of San Francisco School of Law. J.D., 1995
PROFESSIONAL
ORGANIZATIONS
BioScience
Forum (Founder and Past President)
Past Member, Patent Public Advisory Committee (PPAC), USPTO
(2009-2012)
State Bar of
Committee on Professional Responsibility and Conduct (COPRAC; 2013-
2014)
Professional Liability Insurance Availability and Affordability Working
Group
Council of Sections Advisor (2005-2006)
Council of Sections (Co-Chair 2004-2005)
Council of Sections (Co-Vice Chair 2003-2004)
Intellectual Property Section
Legislation Interest Group (Chair 2006-)
Council of State Bar Sections IP Representative
(2004-2006)
Executive Committee (2001-2004)
Patent Standing Committee (1999- )
Special Commission on Proposed USPTO Rules (Chair)
Board of Governor’s Task Force on Sections (Section Representative
2004-2006)
IP Section Delegate, Conference of California Bar Associations
(2007-2010)
Am. Intel. Prop. Law Assoc.
Biotechnology, International law and Patent Committees,
Co-Chair, Patent Policy Subcommittee (2014-)
Co-Chair, Patentability Subcommittee (2011-2014)
Co-Chair, Patent Subcommittee on Section 101
(2009-2011).
Contra Costa County Bar Association, Chair, Business Law Corporate
Counsel Section (2011-2013), Treasurer (2014-)
Federal Circuit Bar Association (past)
Federated Association of Societies for Experimental Biology
(past)
American Lung Association (past)
American Physiology Society (past)
American Association of Cell Biologists (past)
American Chemical Society (past)
American Association of
Pharmaceutical Scientists (past)
PROFESSIONAL
DEVELOPMENT
Originated and maintained legal practice relating to life sciences,
chemistry, semiconductor manufacturing, copyright, IP counseling and IP
transactions, in pharmaceuticals, analytical instrumentation, biotechnology,
genetics, information technology, bioinformatics, immunology, diagnostics,
therapeutics, superconductive materials and semiconductor
processing.
LEGAL
PUBLICATIONS
Borson, D.B. and Leonard,
M.,
Legislation Update, New
Matter 4(1):23-25, 30 (Spring 2015).
Borson, D.B. and Leonard,
M.,
Legislation Update, New
Matter 39(4):19-20 (Winter 2014).
Borson, D.B. Case Summary of AbbVie v. Janssen, Biotech Buzz (16 July
2014).
Borson, D.B. and Leonard,
M.,
Legislation Interest Group Report:
Extract, New Matter 39(1):61-62 (2014)
Schultz, A. & and
Borson, D.B,
Report from the International
Interest Group on Changes in Australian Practice New Matter 39(1):47-48
(2014).
Borson, D.B. Comments on New USPTO Guidance for
Examination of Applications Including Laws of Nature, submitted to USPTO (29
April 2014).
Borson, D.B. Senju v. Apotex, AIPLA Biotech Committee, Biotech
Buzz, (April 18, 2014).
Borson, D. B. Methods Claims Must Recite Specific Steps
Needed to Achieve Results, Smartgene v. Advanced Biological Labs., AIPLA Diagnostics & Gene
Patenting Subcommittee,
Biotech Buzz, February 24, 2014.
Craig, A.G &
Borson, D.B, Addressing Unfair Litigation Practices in
Patent Law, New Matter 38(4):19-23 (Winter
2013)
Borson, D.B. Sunovion v. Teva and Dr.
Reddy’s, AIPLA Biotech
Buzz November 2013
Borson, D.B. Biogen v. GSK, AIPLA Biotechnology Committee
Biotech Buzz,. (April 16, 2013).
Borson, D.B. et al. Annual Report of the Patent Public Advisory
Committee (November 2. 2012).
Borson, D.B. Avoiding Disputes, Keep the Litigants Out of
It. Business Law Corporate Counsel
Section, Contra Costa Lawyer, August 1, 2012.
Borson, D.B. and D. Eastham:
The Leahy-Smith America Invents
Act of 2011: Section 3 of the
Matteo D.C. et al., Annual Report of the Patent Public Advisory
Committee (November 4, 2011).
Borson, D.B. D. Eastham The Leahy-Smith America Invents Act of 2011:
An Introduction. New Matter, 36(4): 5-24
(2011).
Matteo, D.C. et al., Annual Report of the Patent Public Advisory
Committee (November 1, 2010).
Borson, D.B. Proposed Legislation on Patent Reform and
IP, New Matter 34(2):160-161 (2009).
Borson, D.B. Legislation Committee Report of May 4,
2009, New Matter 34(2)60-66 (2009).
Friedman et al., Report of the
Delegation of IP Section of the State Bar of California to Washington D.C.,
April 6, 2009, New Matter 34(2):48-52 (2009).
Borson, D.B. Legislation Committee Report, New
Matter 33(2):50-51 (2008).
Grunebach et
al.,
A Town Focused on Change; IP Law
Section’s 2008 Delegation to DC, New Matter 33(2):40-45
(2008).
Borson, D.B. Assisting with U.S. Patent Prosecution and
Preserving U.S. Patent Rights, In:
U.S. Patent Practice for Paralegals: HalfMoon LLC. pp:4-1 to 4-83
(2008).
Borson, D.B. Note from the Legislation Committee,
New Matter 32(4):4 (2007).
Borson, D.B. Report of the Legislation Committee: USPTO
Final Rules on Claims and Continuations. New Matter 32(2):44-57
(2007).
Mendoza et al.,
Annual D.C. Trip Plays a Key Role
in Maintaining Strong Federal Relationships, New Matter 32(2)34-39
(2007).
Borson, D.B. KSR v. Teleflex, Inc.: The Supreme
Court Reviews Obviousness. J. Patent and Trademark Office Society
89(7):523-544 (2007).
Borson, D.B. KSR v. Teleflex, Inc.: The
Supreme Court Reviews Obviousness.
New Matter 32(1):11-39 (2007).
Borson, D.B. LabCorp v. Metabolite: Legal and Scientific
Terminology: An Example of Poor Correlation. New Matter, 31(3):31-43
(2006).
Borson, D.B. et al., Changes to Practice for Continuing
Applications Requests for Continued Examination Practice and Applications
Containing Patentably Indistinct Claims, Ad-Hoc Commission of California
Attorneys, Comments submitted to USPTO May 3, 2006.
Borson, D.B. Proposed Rules for Patent
Practice: Continuations and Claims.
New Matter 31(2): 16-20 (2006).
Borson, D.B. et al., Comments on Proposed Rules (37 C.F.R. Part
11), Ad-Hoc Committee of Registered
Patent Attorneys, Submitted to USPTO June 10, 2004.
Borson, D.B. Intellectual Property Strategies in
the Life Sciences: Introduction to Biotechnology Patents. IBC Life Sciences, Inc. (November
2003).
Borson, D.B. Current Status of
Borson, D.B Doctrine of Equivalents in Light
of the Supreme Court’s Decision in Festo: Law and Equity in Intellectual
Property.
New Matter 27(2/3): 9-10, 36-43,
(2002).
Borson, D.B. &S.R.Meyer: Intellectual Property
Protection in High Technology Industries: Trade Secrets, Patents, and
Ethics.
State Bar of California Convention, September 7,
2001.
Borson, D.B. State Immunity from Federal Patent and
Trademark Laws, Part II.
New Matter, 26(1-2):5-10 (2001).
Borson, D.B. Protecting Inventions in
Combinatorial Chemistry Cambridge Healthtech
Institute Symposium on Exploiting Molecular
Diversity Refining Small Molecule Libraries (February 12-14,
2001).
Borson, D.B. State Immunity from Federal Patent and
Trademark Laws, Part I. New
Matter 25(2):3-6 (2000).
Borson, D.B. Patenting Inventions in
Combinatorial Chemistry, Journal of Molecular Graphics and Modeling
18(1):63-71 (2000).
Borson, D.B. Overview of Intellectual
Property Protection. In: Intellectual Property
Practice for Paralegals. Half Moon Seminars, LLC. Eau Claire,
WI, pp:I1-I4 (1998).
Borson, D.B. International Patent
Practice. In: Intellectual Property Practice for
Paralegals Half Moon
Seminars, LLC.
Borson, D.B. The Human Genome Project:
Patenting Human Genes and Biotechnology.
Is the Human Genome Patentable Subject Matter? IDEA, Journal of
Law
and Technology, 35(4):461-496 (1995).
Borson, D.B. Health Care: The Big Picture. USF Forum (Oct 24
1994).
Borson, D.B. Extended Parentship Act.
Model Statute In: Adrienne
D. Davis,
Symposium: Surrogacy Legislation in California; USF Law Rev.
28(3): 582 - 588 (Spring 1994).
Borson, D.B., Wong, M., and Carriere, D. Reform of Compassionate Use of Therapeutic
Drugs. In: Daily
Recorder (
INSTRUCTIONAL
ACTIVITIES
Law and Intellectual
Property
2014
Mass Spectrometry Applications in the Life Sciences: develop and
deliver lectures on commercialization and intellectual
property.
2013-14
Society for Brain Mapping and Therapeutics: develop and deliver
lectures on commercialization and intellectual property.
2009-
Contra Costa County Bar Association, Business Law Corporate
Counsel Section: develop, organize and deliver lectures in business
law.
2011-
Australian Biotechnology Organization (AusBiotech): develop and present lectures on
commercialization and international IP law.
2010-
Adjunct Professor of Law, Course Director and lecturer: Biotechnology Law, Patent
Law
2009-
present lectures on
International IP law and commercialization.
2006-
Borson Law Group, PC: develop
and present workshops and lectures on intellectual property
protection, scientific processes, commercialization,
and defense for clients.
2001 -
State Bar of
Intellectual Property Section
Representative to the Conference of Delegates of
Coordinate and implement activities of the Council of State Bar
Sections
Develop and implement strategies
for statewide continuing legal education.
Lectures for State Bar Annual Meeting, 2001-2008
Lectures for State Bar IP Section Annual Institute
Lecture for State Bar of
Chair, Planning Committee for U.S.P.T.O. Symposia, 2003,
2005
Lecturer, State Bar Annual
Meeting, 2003-2006: Overview of IP and Ethics in IP
Practice.
Lecturer, Intellectual Property
Institute, 2002 - 2006. Delivered lectures on
Claim Drafting, Law and Equity in IP, Ethics in IP Practice and IP
overview
Member, Planning Committee for the
Business Law/Intellectual Property
Law Section Third Annual Joint Meeting, La Costa Resort,
2002.
Prepared and delivered lectures on
Patent Claiming Strategies, Business
Aspects of IP law, Legal Ethics in Intellectual Property Practice,
Doctrine of Equivalents and Law & Equity
Member, Planning Committee for Copyright Office Comes to
Author, articles relating to intellectual property
2002 - 2011 BioScience Forum, non-profit, educational
corporation for Life Science professionals: Founder and President: Formerly
Northern California Pharmaceutical Discussion Group. Organize and moderate lectures, panel
discussions and symposia relating to life sciences, regulatory affairs and legal
affairs for scientists, entrepreneurs and professional personnel. Prepare and
present lectures on IP law to life scientists.
1997 - 2006 Fliesler Meyer LLP (Formerly Fliesler, Dubb, Meyer &
Lovejoy LLP)
Develop and implement strategies for teaching attorneys intellectual
property law
Prepare and deliver IP lectures to Attorneys and
Staff.
Develop and present lectures relating to Patent Office procedures and
case law
Prepare and deliver lectures to
universities, businesses and professional
organizations relating to discovery inventions, intellectual
property, life sciences, chemistry and
biotechnology
1997 - 2002 Northern California
Pharmaceutical Discussion Group
Non-profit educational organization (became BioScience Forum).
Organize and moderate lectures in
Life Sciences for business and
professional personnel. Prepare and deliver lectures relating to intellectual property
law.
LEGAL
PRESENTATIONS
Lecture and Panel: Creating Win-Win Scenarios
Between Australia and China:
AusbioTech Invest Conference, Melbourne Australia (2-3
December 2014).
Course Director and
Lecturer: Patent Law of the United States.
Golden Gate
University School of Law, (August – November
2014).
Two Entrepreneurs Walk into
a Bar, Presentation for the John F.
Kennedy University
Innovation Cluster, (June 11,
2014).
Recent Foreign Patent
Legislation and USPTO Rulemaking,
Patent Interest Group teleconference, IP Law Section, State Bar of
California, (April 10, 2014).
Keynote Speaker: Translational Medicine, Education, Policy,
Commercial and IP Issues,
Society for Brain Mapping and Therapeutics, 11th Annual
Convention, Sydney, Australia, (18 March 2014).
Plenary
Lecturer: Commercialization and Protection of
Intellectual Assets in Application to Mass Spectrometry,
Mass Spectrometry Applications in Clinical Laboratory, Annual
Convention, (March 2, 2014).
Multijurisdictional Ethics:
Review of California and USPTO Rules of Professional Responsibility;
State Bar of California
Intellectual Property Law Institute, (November 8,
2013).
Course Director and
Lecturer: Patent Law of the United States.
Golden Gate University School of Law, (August – November
2013).
Invited Speaker, Bringing Inventions to the Wider World:
Protection Strategies and Commercialization;
Society for Brain Mapping
and Therapeutics 10th World Conference on Brian Mapping (May
14, 2013).
Course Director and
Lecturer: Biotechnology Law, Golden Gate University
School of Law, (January – May 2013).
Using Intangible Assets in
Starting and Running a Business.
Business Law Corporate Counsel Section, Contra Costa County Bar
Association, (April 24, 2013).
Course Director and
Lecturer: Patent Law of the United
States.
Golden Gate University School of Law, (August – November
2012).
Getting Started in Business:
How to Advise Start-Up Enterprises. With Peter Sproul,
Contra Costa County Bar Association Business Law Corporate Counsel
Section,
(July 18, 2012).
New United States Patent
Laws and Implications for New Zealand Biotechnology, Speaker, Organizer and Chair,
NZBIO Convention Auckland, New Zealand, (March 26, 2012):
How to Fire your Bad Clients
and Keep the Good Ones.
Business Law Corporate Counsel Section, Contra Costa County Bar
Association
Intellectual Property: An
Element of Success of a Technology Company’s Life Cycle,
Australian Biotechnology
Organization Conference, Adelaide, Australia,
(October 2011).
Workshops on the America
Invents Act of 2011, International and
Commercialization Strategies, Organizer and Speaker,
NZBIO, Auckland & Dunedin New Zealand, (October 2011).
The Leahy-Smith America
Invents Act of 2011.
Intellectual Property Law Section Teleseminar, State Bar of
California:
Copyright Threats to
Companies With Web Designs,
Business Law Corporate
Counsel/Intellectual Property Section presentation with Stuart
West,
Contra Costa County Bar Association, (June 16,
2011).
Tips on Starting an IP
Firm,
State Bar of California IP Section teleseminar, (May 24,
2011).
Course Director and
Lecturer: Biotechnology
Law,
Golden Gate University School of Law, (January – May
2011).
What Every Business Attorney
Needs to Know About Intangible Assets.
Business Law Corporate Counsel Section, Contra Costa County Bar
Association, (April 20, 2011).
Commercialization and
Intellectual Property Strategies, NZBIO
Conference, Auckland, New Zealand, (March 23,
2011).
Organizer and
Speaker: Workshops on International
Intellectual Property and Commercialization Strategies,
University of Otago and Otago Innovation Ltd, Dunedin, New Zealand, (March
2011).
Update on Federal
Legislation and USPTO Rulemaking. State Bar of California
Teleseminar, Cyberlaw program, (January 29,
2011).
Patenting and Patent Law
from Legal and Technical Viewpoints,
State Bar of California Teleseminar, Cyberlaw program, (January 2011).
Creating a World-Wide
Intellectual Property Strategy, NZBIO Annual
Convention, Auckland New Zealand, (March 18, 2010).
Section 101, Utility and
Patentable Subject Matter in the Discovery Arts,
USPTO Biotechnology, Chemical and Pharmaceutical Partnership
Meeting. (September 8,
2010).
International Intellectual
Property Law, Acquisition, Exploitation and Enforcement:
State Bar of California
Section Education Institute, (January 17, 2009).
California and Federal Ethics in Intellectual Property
Law, State Bar of California Annual Meeting,
(September 26, 2008).
Assisting with U.S. Paten Prosecution, In: U.S.
Patent Practice for Paralegals: HalfMoon LLC. (June 26,
2008).
Intellectual Property Basics for
Non-Specialists State Bar of
California Section Education Institute,
(January 18, 2008).
New Patent Legislation and PTO Rule
Changes, State Bar of California Intellectual
Property Institute, (November 10, 2007).
Ethics Issues in Intellectual Property
Practice, State Bar of California
Annual Meeting, (September 28,
2007).
Discovery
Inventions:
UCSF Entrepreneur Camp, (July 30, 2007).
Law of Obviousness in Light of KSR, Pfizer and Takeda: Possible Patent
Strategies,
Silicon Valley Intellectual Property Law Association,
(September 13, 2007).
New Legislation and Case
Law: State Bar of California Intellectual Property Annual Institute,
(November 2007).
International Law Weekend
West. Santa Clara University School of Law,
Santa Clara, California, (February 2-3, 2007).
Patent Practice Nuts and Bolds of
Intellectual Property, State Bar of California Intellectual
Property Section Institute, (November 2006).
Continuing Applications, Fliesler Meyer LLP Training Meeting, November
1, 2006.
Ethics and Multijurisdictional
Intellectual Property Practice, State Bar of California Annual Meeting,
(October 5, 2006).
Patent Practice: Current Strategies and Future
Trends, San Diego Intellectual Property Law
Association, (June 22, 2006).
International Intellectual
Property Protection: Comparisons of U.S. and Foreign Practice Issues for the
General Practitioner,
State Bar of California Annual
Meeting,
(October
2006).
Technology Transfer Systems and
Intellectual Property Protection.
Osaka University Institute of
Scientific and Industrial Research, Osaka, Japan.
Litigation and
Arbitration: Fliesler Meyer LLP,
(2006).
Careers in Science: IP Management and Technology
Transfer, Stanford University, (November 7,
2005).
Resolution of Patentability
Disputes in Europe. UCLA Symposium on International IP
Practice, (September 16, 2005).
Multijurisdictional Ethics:
California and Federal Law: State Bar of California Annual Meeting,
(September 11, 2005).
Patent Strategies for Follow-On
Products.
Trust and Ethics in
Intellectual Property Practice. State Bar of California Intellectual
Property Section Annual Institute, (November 6, 2004).
Patents on Discoveries in the Life
Sciences, State Bar of California Intellectual
Property Section Annual Institute, (November 5, 2004).
Intellectual Property Rights Abroad: How to Obtain,
Maintain and Defend Them, State Bar of California Annual Meeting,
(October 9, 2004).
Ethics in IP and Corporate
Matters. State Bar of California Intellectual
Property Section Annual Institute, (October 8, 2004).
Technology Transfer in the Life
Sciences,
Intellectual Property Strategies for Biotechnology
Inventions, Haas Intellectual Property Workshop, Haas School of Business, UC
Berkeley, (June 11, 2004).
Intellectual Property Ethical
Issues for In-House Counsel. State Bar of California: In House
Litigation Conference, (May 21, 2004).
IP Protection & Provisional Pate4nts for Bio-related
Inventions, UCSF Entrepreneurs’ Discussion Group,
(November 19, 2003).
Post-Festo Update Law and Equity in Intellectual
Property, State Bar of California Annual Intellectual
Property Institute, (November 8, 2003).
Course Director and Lecturer: Intellectual
Property Strategies for Live Science Companies: Introduction to Biotechnology
Patents,
IBC Life Sciences. (November
3-4, 2003).
Discovery Inventions: Scientific and Legal Issues in
Life Sciences Patents, Fliesler Meyer LLP
(formerly Fliesler Dubb
Meyer & Lovejoy LLP), 2003)
Whose Invention is it? University of
California, San Francisco, Innovation
Accelerator. (2003).
Ethics in Intellectual Property
Law practice. Organizer and Moderator, State Bar of California 76th Annual
Meeting, (September 4, 2003).
Current Status of U.S. Patent
Law. Half Moon Seminars, LLC, Eau Claire,
WI, (June 17, 2003).
Protection of Discovery
Inventions in the Life Sciences, BioScience Forum, Milbrae, California (June 18, 2003).
IP Strategies and Implications
in the Life Sciences, In: Symposium: Defining and Defending
Intellectual Property Rights in Biotechnology.
J. Thomas McCarthy Institute of IP and Technology Law
University of San Francisco School of Law, (March 22, 2003).
Intellectual Property Issues in
Medical Devices. Drug
Information Agency, (February 24-26,
2003).
Doctrine of Equivalents in
Light of Recent Case Law Including Festo v. SMC Corp.:
Law and Equity in Intellectual Property.
State Bar of California Fall Intellectual Property
Institute, (November 9,
2002).
Ethics and Intellectual
Property Practice. State Bar of California Fall Intellectual
Property Institute, (November 6-8, 2002).
Patent Claiming and Prosecution
Strategies. Patent Standing Committee, State Bar of California Intellectual
Property Institute, (November 8, 2002).
Ethical Considerations in IP Practice, FDML Staff
Conference, (October 21,
2002).
Doctrine of Equivalents in Light of Festo. v. SMC, J&J v. RES and Symbol Tech. v. Lemelson: Law and Equity in Intellectual
Property,
Intellectual Property Seminar
Series, Fliesler, Dubb,
Meyer & Lovejoy, LLP, (June 27, 2002).
Ethics and Intellectual
Property Practice. State Bar of California 3rd
Annual Spring Meeting, Business Law. Intellectual Property Joint Meeting,
State Bar of California, (May
19, 2002).
European Patents, Intellectual
Property Rights, Trade Secrets, Trademarks and Branding Issues, In: Winning Strategies for Biomedical
Companies in the European
Union, World Trade
Organization of the Bay Area (2002).
Protecting Intellectual
Property in High Technology: Trade Secrets, Patents and Ethics, State Bar of
California Annual Meeting, (September 7, 2001).
Preparing a Patent Application
for Issuance, Half-Moon Seminars for Paralegals,
(June 13, 2001).
Doctrine of Equivalents in
Light of Festo v. Shoketsu
Kinzoku Kogyo Kabushiki Co. and SMC Pneumatics, Inc.
Fliesler Dubb Meyer &
Lovejoy LLP Attorneys’ Meeting,
(March 1, 2001).
Patent Law, Biotechnology and
Current Issues in Biotechnology
Patents: Hastings School of Law: Intellectual
Property Organization, (February 21, 2001).
Keynote Address: Protecting Inventions in Combinatorial
Chemistry, Cambridge Healthtech Conference: Eighth Annual Exploiting Molecular
Diversity:
Refining Small Molecule
Libraries, (February 13, 2001).
Filing Patent
Applications. Fliesler Dubb Meyer &
Lovejoy LLP Staff Conference,
(January 24, 2001).
Patenting Biotechnological and
Pharmaceutical Inventions, Northern California Pharmaceutical
Discussion Group, (December 13, 2000).
State Immunity from Federal
Patent and Trademark Laws: California State Bar Association, IP Law
Section, Patent Standing Committee teleconference,
(2000).
State Immunity from Federal
Patent and Trademark Laws: Fliesler, Dubb, Meyer
& Lovejoy Continuing Legal
Education Program, (June 23, 1999).
Overview of Intellectual
Property International Patent Practice, Half-Moon Seminars, Inc.
Changes to United States Patent
Rules. Fliesler, Dubb, Meyer
& Lovejoy Continuing Legal Education Program,
(1997).
Uses of
SYMPOSIA
ORGANIZED
USPTO Comes to California,
Intellectual Property Law Section of
the State Bar of California, Los Angeles and San
Francisco, California (May 12, 14, 2010).
United States Patent and
Trademark Office TC 1600 West Coast Road Show 2010, Organizer and
Moderator,
BioScience Forum, Millbrae,
California, (February 24, 2010).
United States Patent and Trademark Office TC 1600 West
Coast Road Show 2008, Organizer and Moderator,
BioScience Forum, Millbrae, California (November
12,
2008).
United States Patent and Trademark Office TC 1600 West
Coast Road Show 2007, Organizer and Moderator,
BioScience Forum, Millbrae, California (October
31, 2007).
United States Patent and Trademark Office TC 1600 West
Coast Road Show 2005, Organizer and Moderator,
BioScience Forum, Millbrae, California (October
18, 2005).
Pain: Mechanisms and Therapeutics, Organizer and
Moderator,
BioScience Forum, Millbrae, California, (November
19, 2004).
Hot Topics in Biotechnology Patent Law: USPTO Technology
Center 1600,
BioScience Forum, Millbrae California, (September
9, 2004).
Application of Biomarkers to the Drug Discovery and
Development Process, Organizer and Moderator,
BioScience Forum, Millbrae, California (June 25,
2004).
Clinical Trials Symposium: The Impact of Regulatory
Changes on Strategic Planning for Clinical Trials,
BioScience Forum, San Mateo, (8 January
2003).
Current Topics in Protein and Drug Binding: Conceptual,
Clinical and Regulatory Issues, Organizer and Moderator,
BioScience Forum, Millbrae, California (May 9,
2002).
United States Patent and Trademark Office Symposium: Hot Topics in Biotechnology
&
Software Patents and New Legislation, Organizer and
Moderator,
Northern California
Pharmaceutical Discussion Group, Millbrae, California (September 20,
2000).
EMPLOYMENT IN
SCIENCE
1976 - 1992 University of
Developer and lecturer,
cardiovascular, pulmonary, gastrointestinal and renal
physiology
Developer and lecturer: National
Board Review Program in Physiology and Biochemistry, School of Dentistry,
Combined
lecture/laboratory program in Physiology: Physical Therapy Program
Designed courses, prepared course
materials, prepared and delivered
lectures, wrote and evaluated examinations, supervised student
laboratories, individual tutorials
Cardiovascular Research Institute University of California San
Francisco:
Prepared and delivered numerous
lectures relating to scientific research at
University, National and International meetings
Taught and supervised staff and
post-doctoral fellows relating to scientific
investigations in neuroscience, physiology, molecular biology,
biochemistry and pharmacology.
Supervised post-doctoral fellows
in scientific writing for publications
Mentored post-doctoral fellows in drafting research
grants
1986-1992 Adjunct
Lecturer, Department of Physiology, UCSF
1986-1992
Assistant Research Physiologist, Cardiovascular Research
Institute, UCSF
1983-1986 Post
Doctoral Fellow, Cardiovascular Research Institute,
UCSF
EMPLOYMENT IN OTHER
DISCIPLINES
1969 - 1977 Federal Aviation
Administration Certified Flight Instructor, Airplane and Instrument; Ground
Instructor: Airplane, Private,
Commercial, Instrument and Multi-engine pilot ratings. President, Buchanan Flying Club
1960-
Concert
flutist
Performances of Baroque, Classical, Romantic, Modern, and Avant Garde music, orchestral, chamber works, and solo
performances
1960 - 1968 Flute
Instructor
Instructed private students and master classes, President, Bay Flute
Club
HONORS AND
AWARDS
2014
Member, Committee on Professional
Responsibility and Conduct, State Bar of California
2010-
Adjunct Professor of Law,
Golden Gate University School of Law.
2014-
Treasurer, Business Law
Corporate Counsel Section, Contra Costa County Bar
Association.
2014-
Co-Chair, AIPLA Patent Law
Committee, Subcommittee on Patent Policy.
2010-2013 Chair, Business Law Corporate Counsel
Section, Contra Costa County Bar Association.
2009-2012 Member, Patent Public Advisory
Committee, USPTO
2009-2011 Co-Chair, AIPLA Subcommittee on Section
101, Patent Committee
2011-2013 Co-Chair, AIPLA Patent Law Subcommittee
on Patentability.
2009-2011 Delegate from IP Section of California
State Bar to the Conference of California Bar Associations
2007-2009 Delegate from IP Section of California
State Bar: Conference of Delegates of California Bar
Associations
2006-
Chair, Intellectual Property
Law Section Legislation Interest Group
2004-2006 Member, Board of Governor’s Task Force on
Sections, State Bar of California.
2004-2008 Advisor, Intellectual Property Law
Section, State Bar of
2006-
Member, IP Law Section and
International Law Section, State Bar of California
2004-2006 Chair, Intellectual Property Section
Commission on Proposed USPTO Rules of Professional
Responsibility.
2003-2005 Co-Vice Chair (2003), Co-Chair
(2004-2005)
Council of State Bar of CaliforniaSections
2002-
Founder and President, BioScience Forum, non-profit life sciences educational
corporation
2002-2004 IP Section Representative: Council of
Sections: State Bar of California.
2001-2004 Member: Executive Committee: State Bar
of California Intellectual Property Section
2001-
Member: Intellectual Property
Advisory Committee: USF School of Law
2000- 2002 Chair, Northern California
Pharmaceutical Discussion Group
1999 -
Member, Patent Standing
Committee, State Bar of
1999-2000 Chair-Elect, Northern California
Pharmaceutical Discussion Group
1998-2000 Advisory Board, Board of Directors:
Northern California Pharmaceutical Discussion Group.
1994-1996 Board of Directors, Balboa Terrace
Homes Association
1991
Member, Special Review Committee,
National Institute of Health:
National Heart, Lung, and
1990 -
Biography listed
in:
Who’s Who in the World
Who’s Who in
Who’s Who of American Attorneys
Who’s Who in Science and Technology
Who’s Who in Education
Who’s Who in the West
1989-1994 NIH Program Project Grant: HL 24136
Project D7:
Modulation of Airways by Neutral Endopeptidase
1988-1991 Cystic Fibrosis Research Development
Program Grant: RO 149-1
Neuropeptide Release from Airways
1989 to 1992 Editorial Board, American Journal of
Physiology: Lung Cellular and
Molecular Physiology
1987-1992 Principle Investigator, NIH First
Independent Research Service and
Transition Award: HL-38947,
Role of Enkephalinase in
Regulating Airways.
1987
Co-inventor: Therapeutic
Use of Enkephalinase
U.S. Patent No. 5,262,178 issued 1993
U.S. Patent No. 5,403,585 issued 1995.
1986-1987 UCSF Academic Senate Committee on Research
Grant:
Regulation of Release of Airway Glycocalyx
by Proteinases
1985-1986 UCSF Research Education and Allocation
Committee Grant:
Effects of Peptides and Proteinases on Airway
Secretion.
1984-1989 NIH Program Project Grant: HL 24136:
Project D7:
Regulation of Airway Secretion.
1984-1986 American Lung Association of
Roles of Inflammatory Peptides in Regulating Mucus
Secretion
1984 - 1986 Parker B. Francis Research
Fellowship
1984
Cystic Fibrosis Research
Fellowship
1983 - 1984 United States Public Health Service
Postdoctoral Fellowship
1976 - 1982 United States Public Health Service
Predoctoral Traineeship
SCIENTIFIC
EXPERIENCE
1990 - 1992 GENENTECH, INC.,
Genetics: Visiting
Scientist.
Original Scientific
Research
Designed and carried out studies
in biochemistry, molecular biology, gene expression, cell culture, cellular
transformation & mutagenesis of a mammalian cell surface enzyme with
therapeutic utility.
1986 - 1992 UNIVERSITY OF
Cardiovascular Research Institute, Assistant Research
Physiologist
Original Scientific
Research:
Ran biomedical research
laboratory, Trained Staff and
supervised post-doctoral fellows.
Physiology and
Pharmacology, Designed and carried out
physiological and
pharmacological studies on glycoprotein secretion, regulation of muscle
action, reflexes interaction of different branches of the nervous
system,
hormonal regulation in vivo and in vitro.
Biochemistry: Designed and carried out biochemical studies of
peptide
degradation, enzyme purification, neurotransmitter release, and macro
molecular secretion.
Molecular Biology and
Genetics: Designed and carried out molecular
biological
studies on gene transcription, translation, and product translation of
endogeneous and exogeneous genes in tissues and cell culture.
Wrote and administered research grants
Authored over 80 publications in mammalian physiology,
biochemistry, and
molecular biology relating to neural and humoral regulation of
mammalian organ systems
Inventor
Therapeutic Use of Enkephalinase. Two
Issued Patents
Teacher
Physiology, cell biology, biochemistry, molecular biology, scientific
research methods, scientific writing
Service to Scientific
Community: Reviewed manuscripts and grants. Presented lectures and seminars, and
chaired scientific meetings.
1986 - 1992 UNIVERSITY OF
Department of
Physiology, Adjunct
Lecturer
Lectures and Laboratories: Physiology, pharmacology and biochemistry
for students in Medical, Pharmacy, Dentistry and Physical Therapy
programs.
1983 - 1986 UNIVERSITY OF
CALIFORNIA, SAN FRANCISCO
Cardiovascular Research Institute, Postdoctoral
Fellow
Original Scientific Research:
Neural and humoral regulation of the
respiratory system
SELECTED INVITED SCIENTIFIC
LECTURES
1983
National Institutes of Health, Clinical Staff Conference Neurohumoral Regulation of Airway
Secretion
1983
University of Hawaii, Clinical Physiology Conference Inflammatory
Regulation of Airway Secretion
1984, 1986 Vicks Division of
Research: Conference on Respitory Secretions Neurohumoral Regulation of Airway
Secretion
1988
Transatlantic Airways Conference, Lucerne, Switzerland Roles of
Neutral Endopeptidase in Regulating
Airways
1988
University of California, San Francisco: Department of Physiology
Roles of Peptides and Proteinases in Regulating Airway Functions
1988
International Conference on Rhinitis and Asthma, Smygehamn, Sweden Airway
Secretions.
1988
Third Annual Conference on Clinical Immunology, San Francisco
Neuropeptides and the Lung: Animal Models and Human
Disease
1988
UCSF Quality Assurance and Clinical Conference; Adult Allergy Faculty
Practice; Neuropeptides and Lung Reactions.
1989
Temple University Pulmonary Division; Conference on Proteases in
Disease: Role of Neutral Endopeptidase in
Airways
1989
University of Pennsylvania Department of Pediatrics and Physiology
Roles of Neutral Endopeptidase in Regulating
Peptide-Induced Phenomena
1989
Temple University Department of Physiology Role of Neutral Endopeptidase in Regulating Peptide-Induced
Responses
1990
XIII International Congress of Asthmology
Neutral Endopeptidase as a Possible
Anti-inflammatory Drug
1990
Dokkyo University Roles, Regulation, and Therapeutic
Potential of Neutral Endopeptidase
1990
Women’s
1991
Stanford University School of Medicine; Cystic Fibrosis Research Group
Roles and Regulation of Neutral Endopeptidase
PATENTS PREPARED, PROSECUTED
1.
Jui H. Wang et al.,
Poly-Substituted-Phenyl-Oligoribonucleotides Having Enhanced Stability and
Membrane Permeability and Methods of Use, U.S. Pat. No: 5,858,988, issued
Jan 12, 1999.
2.
Herbert E. Schwartz et al., Bioresorbable Compositions of
Carboxypolysaccharide Polyether Intermacromolecular Complexes and Methods for
Their Use in Reducing Surgical Adhesions. U.S. Pat. No: 5,906,997, issued
3.
Radu Barsan et al.,
Use of Borophosphorous Tetraethyl Orthosilicate (BPTEOS) to Improve Isolation in a Transistor
Array.
4.
James E. Currie et al., Planarization Composition for Removing Metal
Films. U.S. Pat. No: 5,993,685,
issued
5.
Ashraf R. Khan et al., Surface Modification of Semiconductors Using
Electromagnetic Radiation. U.S.
Pat. No: 6,015,759, issued
6.
Herbert E. Schwartz et al., Bioresorbable Compositions of
Carboxypolysaccharide Polyether Intermacromolecular Complexes and Methods for
Their Use in Reducing Surgical Adhesions. U.S. Pat. No: 6,017,301, issued
7.
Chung J. Lee et al., Precursors for Making Low Dielectric Constant
Materials with Improved Thermal Stability. U.S. Pat. No: 6,020,458, issued
8.
Herbert E. Schwartz et al., Bioresorbable Compositions of
Carboxypolysaccharide Polyether Intermacromolecular Complexes and Methods for
Their Use in Reducing Surgical Adhesions. U.S. Pat. No: 6,034,140, issued
9.
Giovanni Antonio Foggiato et al., Large Area
Discharge Excitation Radiator.
U.S. Pat. No: 6,049,086, issued
10. Chung J.
Lee et al., Low Dielectric Constant Materials and Method. U.S. Pat. No:
6,051,321, issued
11. Sunil D.
Mehta et al., Annealing of Silicon Oxynitride and Silicon Nitride Films to
Eliminate High Temperature Charge Loss. U.S. Pat. No: 6,071,784, issued
12. David Leksell et al., Chamber for Reducing Contamination During
Chemical Vapor Deposition..
U.S. Pat. No: 6,079,353, issued
13. Chung J.
Lee et al., Deposition Systems and Processes for Transport Polymerization and
Chemical Vapor Deposition. U.S.
Pat. No: 6,086,679, issued
14. Gouxi Pan, High Hardness and Wear-Resistant Flux Cored
Wire. U.S. Pat. No: 6,103,997,
issued
15. David Leksell et al., Chamber for Reducing Contamination During
Chemical Vapor Deposition. U.S.
Pat. No: 6,114,227, issued
16. Herbert E.
Schwartz et al., Bioresorbable Compositions of Carboxypolysaccharide
Polyether Intermacromolecular Complexes and Methods for Their Use in Reducing
Surgical Adhesions. U.S. Pat. No: 6,133,325, issued
17. Chung J.
Lee et al., Chemicals and Methods for Making Fluorinated
Poly(Para-Xylylenes). U.S. Pat.
No: 6,140,456, issued
18. Yue-Song He et al., Barrier Layer Decreases Nitrogen
Contamination of Peripheral Gate Regions During Tunnel Oxide
Nitridation. U.S. Pat.
No: 6,143,608, issued
19. Zoran Krivokapic, Convex Device with Selectively Doped
Channel. U.S. Pat. No:
6,153,454, issued
20. William
Oppelt, et al., Laparoscopic Insertion and
Deployment Device, U.S. Pat.
No: 6,193,731, issued
21. Lu You et al.,
Cure Process for Manufacture of Low Dielectric Constant Interlevel Dielectric
Layers. U.S. Pat. No:
6,200,913, issued
22. Jonathan
Lin et al., Improving Field Leakage by Using a Thin Layer of Nitride
Deposited by Chemical Vapor Deposition. U.S. Pat. No: 6,211,022, issued
23. Lu You et
al., Rapid Acceleration Methods for Global Planarization of Spin-On
Films. U.S. Pat. No: 6,225,240,
issued
24 Effiong Ibok, Graded Anti-Reflective Barrier Films
for Ultra-Fine Lithography
U.S. Pat. No: 6,235,456, issued
25. Chung J.
Lee et al., Precursors for Making Low Dielectric Constant Materials with
Improved Thermal Stability.
U.S. Pat. No. 6,258,407 B1, issued
26. James E.
Currie et al., Planarization Compositions for Removing Metal Films. U.S. Pat. No. 6,267,909, issued
27. Jui H. Wang.
Antiviral Anticancer Poly-Substituted Phenyl Derivatized
Oligoribonucleotides and Methods for Their Use. U.S. Pat. No. 6,291,438, issued
28. Hyeon-Seag Kim et al., Process for Manufacturing Shallow
Trenches Filled With Dielectric Material Having Low Mechanical Stress. U.S. Pat. No: 6,297,128, issued
29. Seshu B. Desu et al., Near-Room
Temperature Thermal Chemical Vapor Deposition of Oxide Films, U.S. Pat. No:
6,316,055, issued
30. Lu You et
al., Apparatus and Methods for Uniform Scan Dispensing of Spin on
Materials. U.S. Pat. No:
6,317,642, issued
31. David Greenlaw et al., Process to Separate the Doping of
Polygate and Source Drain Regions in Dual Gate Field Effect
Transistors. U.S. Pat. No:
6,319,804, issued
32. Richard
Brewer, Thomas J. Grebinski, James E. Currie, Michael Jones, William Muller, and
Ann Nguyen, Planarization Compositions
and methods for Removing Interlayer Dielectric Films, U.S. Patent No.
6,122,600, issued November 27, 2001.
33. Chung J.
Lee et al., Low Dielectric Constant Materials with Improved Thermal and
Mechanical Properties. U.S.
Pat. No: 6,323,297, issued
34. Seshu B. Desu et al.,
Oxide/Organic Polymer Multilayer Thin Films Deposited by Chemical Vapor
Deposition. U.S. Pat. No: 6,358,863 B1, issued
35. Lu You et
al., Solution Flow-In for Uniform Deposition of Spin-on
Films.
U.S. Pat. No: 6,387,825, issued
36. Lu You et
al., Methods of Manufacture of Uniform Spin-On Films. U.S. Pat. No: 6,407,009, issued
37. Hyeon-Seag Kim, Gate Insulator Process for Nanometer
Mosfets. U.S. Pat.
No: 6,413,826, issued
38. Effiong Ibok, Method for
Fabricating High Permitivity Dielectric Stacks Having
Low Buffer Oxide. U.S. Pat. No:
6,417,041, issued
39. Heyon-Seag Kim et al., Process for Manufacturing Shallow
Trenches Filled With Dielectric Material Having Low Mechanical Stress. U.S.
Pat. No: 6,455,912, issued
40. Desu et al., Near-Room Temperature
41. Lu You et
al., Closed Deposition Apparatus and Methods for Regulating Drying of Spin-On
Films. U.S. Pat. No: 6,530,340
B2, issued
42. Chung J.
Lee et al., Precursors for Making Low Dielectric Constant Materials With
Improved Thermal Stability.
U.S. Pat. No: 6,534,616, issued
43. Raisa V. Talroze and Leonid N.
Grigorov, Conductive Polymer Materials and Methods
for Their Manufacture and Use, U.S. Pat. No: 6,563,132, issued
44. Mark E.
Miller et al., Polyacid/Polyalkylene Oxide Foams and Gels and Methods for
Their Delivery, U.S. Pat. No: 6,566,345 B2, issued
45. Peter D.
Gluckman et al., Regulation of Tyrosine
Hydroxylase. U.S. Pat. No: 6,617,311 B1, issued
46. Chung J.
Lee et al., Low Dielectric Constant Materials Prepared From Photon or Plasma
Assisted Chemical Vapor Deposition and Transport Polymerization of Selected
Compounds. U.S. Pat. No:
6,663,973, issued
47. Tajrena Alexi, Methods for Promoting Weight Gain Using
GPE-Related Compounds. U.S.
Pat. No: 6,682,753 B2, issued
48. David I.
Kreimer et al., Systems and Methods for Filter
Based Spectrographic Analysis.
U.S. Pat. No: 6,707,548, issued
49.
50. Peter Gluckman et al., Use of GPE to Protect Glial Cells or
Non-Dopaminergic Cells From Death From Neural Injury of Disease. U.S. Pat.
No: 6,780,848, issued
51. Peter Gluckman et al., Methods to Improve Neural
Outcome. U.S. Pat. No:
6,812,208, issued
52.
53. Raisa Talroze et al.,
Conductive Polymer Materials and Methods for their Manufacture and Use, U.S. Pat. No: 6,844,567, issued
54. Lance
Hunter, Shaving Cream Dispenser.
U.S. Pat. No: 6,860,413, issued
55. Herbert
Schwartz et al., Compositions of Polyacids and Polyethers and Methods for
Their Use in Reducing Adhesions.
U.S. Pat. No: 6,869,938, issued
56. Allan
Gardiner et al., Illuminator with Filter Array and Bandwidth
Controller. U.S. Pat. No:
6,886,964, issued
57. Lin-Shu Lin et al., Chemically Activated
Carboxypolysaccharides and Methods for Use to Inhibit Adhesion Formation and
Promote Hemostasis. U.S. Pat.
No: 6,923,961, issued
58. Christopher
Williams, Processing EEG Signals to Predict Brain Damage. U.S. Pat. 6,931,274, issued
59. Mark
Vickers et al., Treatment of Hypertension Using Growth Hormone in Mammals
Subjected to Fetal Programming.
U.S. Pat. No: 6,933,278, issued
60. Peter Gluckman et al., Regulation of Tyrosine Hydroxylase by
GPE. U.S. Pat. No: 6,933,282,
issued
61. Leonid
Grigorov et al., Quantum Devices Based on
Crystallized Electron Pairs and Methods for Their Manufacture and Use. U.S. Pat. No: 7,014,795, issued
62. Norman
Abood et al., GPE Analogs and Peptidomimetics,
U.S. Pat. No: 7,041,214, issued
63. William
Oppelt et al., Hemostatic Compositions of Polyacids and Polyalkylene Oxides
and Methods for Their Use.
Australian Patent No: 2001255716.
64.
Peter Gluckman et al., GPE Analogs. U.S. Pat. No: 7,112,570, issued
65. Chung Lee
et al., Precursors for Making Low Dielectric Constant Materials With Improved
Thermal Stability. Korean
Patent No: 602222, registered
66. Chung Lee
et al., New Deposition Systems and Processes for Transport Polymerization and
Chemical Vapor Deposition.
Korean Patent No: 621226, registered
67. Constance
Haber et al., Therapeutic Methods Using Electromagnetic Radiation. U.S. Pat. No: 7,150,710, issued
68. Geoffrey
Krissansen et al., Treatment of Demyelinating
Diseases. U.S. Pat. No:
7,192,931, issued
69. Richard
Berg et al., Compositions of Polyacids and Polyethers and Methods for Their
Use as Dermal Fillers. U.S.
Pat. No: 7,192,984, issued
70. Mark Miller
et al., Polyacid/Polyalkylene Oxide Gels and Methods for Their Delivery,
U.S. Pat. No; 7,265,098, issued
71. David Batchelor et al., Methods for Detecting Weakly
Immunogenic Analytes. U.S. Pat.
No: 7,282,432, issued
72. Michael
Powell, Diagnosis and Treatment of Human Dormancy Syndrome, U.S. Pat. No: 7,288,257, issued
73. Arjen Scheepens et al.,
Neuroprotective Effect of Growth Hormone. U.S. Pat. No: 7,304,029, issued
74. Angel
DeCegama, Methods for Real-Time Software Video/Audio Compression,
Transmission, Decompression and Display. U.S. Pat. No: 7,317,840, issued
75. Anthony
Reeve et al., Medical Applications of Adaptive Learning Systems Using Gene
Expression Data. U.S. Pat. No:
7,370,021, issued
76. Seiya Imoto et al., Biological Discovery Using Gene Regulatory
Networks Generated from Multiple-Disruption Expression Libraries. U.S. Pat.
No. 7,430,475, issued
77. Michael
Powell. Diagnosis and Treatment of Human Dormancy-Related Sequellae, U.S.
Pat. No: 7,485,298, issued
78. Paul
William Richard Harris et al., Neuroprotective Macrocyclic Compounds and
Methods for Their Use, U.S. Pat. No: 7,485,630, issued
79. Ron Tolmei,
Activation of Remote Control Transmitter
Functions by External Inputs. U.S. Pat. No: 7,535,401, issued
80. Norman A.
Abood and Margaret Anne Brimble, GPE Analogs
and Petpidomimetics, European Patent No: EP 1 401
808 B1, granted 8 July 2009.
81. Frank Sieg, Edmund Hughes, Thorsten Gorba, Neural
Regeneration Peptides and Methods for Their Use in Treatment of Brain
Damage, U.S. Pat. No: 7,563,862, issued
82. Paul V.
Lehmann, Alexey Y. Karulin, and Thomas Oliver Kleen, Nanoparticle
and Microparticle Based Detection of Cellular
Products. U.S. Pat. No:
7,598,093, issued
83. Peter David
Gluckman, Gregory Brian Thomas, Jian Guan, Michael Dragunov, Ashmit Kumar Anand, Frank Sieg, and Margaret Anne Brimble,
Effects of Glyucyl-2 Methyl-Prolyl Glutamate on Neurodegeneration.
U.S. Pat. No: 7,605,177, issued
84. Frank Sieg, Edmund Hughes, Thorsten Gorba, Neural
Regeneration Peptides and Methods for Their Use in Treatment of Brain
Damage, Japanese Patent No: 4,399,260, issued
85. Frank Sieg et al. Neural Regeneration Peptides and Methods for
Their Use in Treatment of Brain Damage. Japanese Patent No. 4,399,260, issued
86. Michael
Powell, Diagnosis and Treatment of Human
Dormancy Syndrome, U.S. Pat. No: 7, 648,704, issued
87. Ron Tolmei,
Means, Methods, and Apparatus to Reduce
the Possibility of a Motor Vehicle Entering a Freeway Ramp in the Wrong
Direction of Travel, Towards Oncoming Traffic,. U.S. Pat. No: 7,650,236, issued
88. Peter David
Gluckman, Margaret Anne Brimble, Douglas Wilson, Frank Casper Tortella, Anthony Joseph Williams, Xi-Chun May, Jed. A.
Hartings and Devina Gryder, Treatment of
Non-Convulsive Seizures in Brain Injury Using G-2-Metheyl-Prolyl-Glutamate,
U.S. Pat. No: 7,714,020, issued
89. Allan
Gardiner and Brent Michael McCullough, Systems and Methods for Displaying Changes
in Biological Reponses to Therapy, U.S. Pat. No: 7,720,306, issued
90. Frank
Ernest Aldwell, Bryce Malcolm Buddle, and Ian George
Tucker, Antigenic Compositions, U.S.
Pat. No: 7,758,869, issued
91. Frank Sieg et al. Neural Regeneration Peptides and Methods for
Their Use in Treatment of Brain Damage. U.S. Pat. No. 7,776,786, issued
92. Au-Yeung
Kwok-Leung and Lee B. Bussey. Apparatus and Methods for Preparative Scale
Purification of Nucleic Acids, U.S. Pat. No. 7,771,945, issued
93. Margaret
Anne Brimble and Jian Guan,
Cyclic G-2AllylProline in Treatment of
Parkinson’s Disease, U.S.. Pat. No. 7,776,876, issued August 17,
2010.
94. Robert
Bridenbaugh, Warren Dang, and Lee B. Bussey, Methods for
Purifying Nucleic Acids. U.S.
Pat. No. 7,807,822, issued
95. Margaret
Anne Brimble, Paul William Harris, and Frank Sieg, Analogs of
Glycyl-Prolyl-Glutamate,
U.S. Pat. No. 7,863,304, issued
96. Constance
Haber and Allan Gardiner, Therapeutic
Methods Using Electromagnetic Radiation,
97. Jingyuan Wen, Gregory Brian Thomas, Mike John Bickerdike, Oral
Formulations of Glycyl-2-Methyl
98. Constance
Haber and Allan Gardiner, Therapeutic
Methods Using Electromagnetic Radiation,
99. Hjalmar Nekarda, Jan Friederichs, Bernhard Holzmann,
Robert Rosenberg, Anthony Edmund Reeve, Michael Alan Black, Johan Lindsay
McCall, Yu-Hsin Lin, and Robert Craig Pollock,
Prognosis Prediction for Colorectal Cancer, Singapore Patent No. 143,707,
granted 29 April 2011.
100. Ron Tolmei, Visual Indicator for Electrosurgical
Instrument Fields, U.S. Pat. No. 7,963,957, issued June 21,
2011.
101. Paul William Richard
Harris and Margaret Anne Brimble, Neuroprotective Macrocyclic
Compounds and Methods for Their Use, U.S. Pat. No. 8,013,170, Issued
September 6, 2011.
102. Frank Ernest Aldwell, Bryce Malcolm Buddle and Ian George Tucker, Antigenic Compositions, Chinese Patent
No. ZL 02817408.9, Issued 7 September 2011.
103. Angel DeCegama, Systems and Methods for Compression,Transmission and Decompression of Video
Codecs, U.S. Pat. No. 8,031,782, issued October 4,
2011.
104. Margaret Anne Brimble et al., Neuroprotective Bicyclic Compounds and
Methods for Their Use, Japanese Patent No. 4842817, granted 14 October
2011.
105. Margaret Brimble, Jian Guan, Frank Sieg, Neuroprotective Bicyclic Compounds and Methods for Their
Use, U.S. Pat. No.8,067,425, issued November 29, 2011.
106. Michael Powell. Diagnosis and Treatment of Cancer Related to
Human Dormancy, U.S. Pat. No. 8.075,902, issued December 13,
2011.
107. Ron Tolmei. Centre High Mount Stop Lamp with Constituent
Seatbelt Disengagement Indicator, U.S. Pat. No. 8.081,068, issued
108. Paul V. Lehmann, Alexey
V. Karulin, and Thomas Oliver Kleen, Nanoparticle
and Microparticle Based Detection of Cellular
Products, U.S. Pat. No. 8,088,630, issued
109. Tim Zapalski, Apparatus
and Method for Generating and Tracing Vortices, U.S. Pat. No. 8,146,893,
issued
110. Kwok-Leung Au-Yeung and
Lee Bussey, Apparatus and Method for Preparative Scale
Purification of Nucleic Acids, U.S. Pat. No. 8,158, 348, Issued
111. Jingyuan Wen, Gregory Brian Thomas, Mike John Bickerdike, Oral
Formulations of Glycyl-2-Methyl
112. Samuel Nochumson, Ross Durland, Audrey
Yu-Speight, John Welp, Kouwei Wu, and Rexford Hayes, Process and Equipment for Plasmid
Purification, U.S. Pat. No. 8,236,495, issued August 7,
2012.
113. Noah Groth, Jan P.
Warhuus, and Krassimir Anastassov Boyadjiev, Data Center Equipment Locator and Monitoring
System, U.S. Pat. No. 8,264,354, issued September 11,
2012.
114. Quentin Lewis Hibben, Low
Temperature Curable Adhesive Compositions, U.S. Pat. No. 8,334,346, Issued
December 18, 2012.
115. Allan Gardiner and Tai
Huynh, Therapeutic Methods Using
Electromagnetic Radiation, U.S. Pat. No. 8,343,026, Issued January 1,
2013.
116. Michael Powell, Diagnosis and Treatment of Human Dormancy
Related Sequellae, U.S. Pat. No. 8,343,485, Issued January 1,
2013.
117. Leonid Grigorov, Methods and
Devices for Programmable Delivery of Microdoses of
Liquid Drugs and Other Fluids, U.S. Pat No. 8,435,212, Issued May 7,
2013.
118. Frank Aldwell, Bryce Malcolm Buddle, and Ian George Tucker, Antigenic Compositions. Canadian Patent No. 2,454,920, Granted
25 June 2013.
119. Jingyuan Wen, Gregory Brian Thomas, and Mike John Bickerdike, Oral
Formulations of Glycyl-2-Methylprolyl-Glutamate, U.S. Patent No. 8,496,963,
Issued July 30, 2013.
120. Angel DeCegama, Systems and Methods for Compression,
Transmission and Decompression of Video Codecs, U.S. Patent No. 8,503,543,
Issued August 6, 2013.
121. Joseph A. Mendoza, Remote Key Device, U.S. Patent No.
8,511,122, Issued August 20, 2013.
122. Mike John Bickerdike, Margaret Anne Brimble,
and Ernest Stephen Siritmanne, Cyclic-Clycyl-2-Allyl Proline and Its Use in Treatment of Peripheral
Neuropathy, U.S. Patent No. 8,519,127, issued August 27,
2013
123. Ashraf R. Khan, Sasangan Ramanathan, and Giovanni
Antonio Foggiato, Surface Modification of Semiconductors Using
Electromagnetic Radiation, European Patent No. 1,038,307, granted 11
September 2013.
124. Peter David Gluckman, Jian Guan, Mary-Anne
Woodnorth, and Margaret Anne Brimble, Method for
Cognitive Enhancement and Cognitive Therapy Using Glycyl-2-Methyl Prolyl Glutamate.
U.S. Patent No. 8,637, 567, issued January 28,
2014.
125. Hjalmar Nekarda, Jan Friederichs, Bernhard Holzmann,
Robert Rosenberg, Anthony Edjund Reeve, Michael Alan
Black, John Lindsay McCall, Yu-Hsiu Lin, and Robert
Craig Pollock, Prognosis Prediction for
Colorectal Cancer, Hong Kong Patent No. HK1127125, granted 28 February
2014.
126. Robert Bridenbaugh, Warren Dang, and Lee Bussey, Methods for
Purifying Nucleic Acids, U.S. Patent No. 8,680,261, issued March 25,
2014.
127. Jingyuan Wen, Gregory Brian Thomas, Mike John Bickerdike, Oral
Formulations of Glycyl-2-Methylprolyl-Glutamate, European Patent No. EP 2
001 400 B1, granted 7 May 2014.
128. Noah Groth, Jan P.
Warhuus, and Krassimir Anastassov Boyadjiev, Data Center Server Location and Monitoring
System, U.S. Patent No.
8,779,922, issued July 15, 2014.
129. Michael John Bickerdike and
Jian Guan, Cyclic Glycyl-2-AllylProline Improves
Cognitive Performance in Impaired Animals, U.S. Patent No. 8,791,117, issued
July 29, 2014.
130. Michael Alan Black,
Jonathan Cebon, Parry John Guilford, and Thomas John,
Prognosis Prediction for Melanoma
Cancer, U.S. Patent No. 8,822,149, issued September 2,
2014.
131. Halmar Nekarda et al., Prognosis Prediction for Melanoma
Cancer, Japanese Patent No. 5632581, granted October 17,
2014.
132. Leonid Grigorov, Methods and
Devices for Programmable Delivery of Microdoses of
Liquid Drugs, U.S. Patent No. 8,876,802, issued November 4,
2014.
133. Samuel Falcone and
Richard Berg, Carboxymethylcellulose Polyethylene Glycol
Compositions for Medical Uses, Australian Patent No.
2008-330166, granted 8 January 2015.
134. Noah Groth, Jan Warhuus, and Krassimir Anastassov Boyadjiev, Data Center Equipment Location and
Monitoring System, U.S. Patent No. 8,994,532, issued March 31,
2015.
TRADEMARK REGISTRATIONS
1.
IMMUNOSCAN, U.S. Reg. No.
3,182,039, Reg. Date: December 5, 2006, Cellular Technology Limited.
2.
SPOTMAP, U.S. Reg. No.
3,221,091. Reg. Date: March 27,
2007, Cellular Technology Limited
3.
IMMUNOSPOT, U.S. Reg. No.
3,438,787, Reg. Date: June 3, 2008, Cellular Technology Ltd.
4.
5.
“Photomed Ribbon” Misc. Design, Reg. No.3,468,580. U.S. Reg. Date: July 15, 2008, Photomed
Technologies, Inc.
6.
SIMPL, U.S. Reg. No.
3,680,118, Reg. Date: September 8,
2009, MSM Protein Technologies, Inc.
7.
OASIS, U.S. Reg. No.
3,532,352. Reg. Date: November 11, 2008, Thomas Grebinshi.
8.
BIOSPOT, U.S. Reg. No.
3,544,006, Reg. Date: December 9, 2008, Cellular Technology Ltd.
9.
UVSPOT, U.S. Reg. No.
3,602,913, Reg. Date: April 7, 2009, Cellular Technology Ltd.
10. PHOTOMED TECHNOLOGIES (and Design), U.S. Reg. No.
3,612,813. Reg. Date: April 28,
2009, Photomed Technologies, Inc.
11. EPBMC, U.S. Reg. No. 3,753,512. Reg. Date: March 2, 2010, Cellular
Technology Ltd
12.
LIPORALE, AU Reg. No.
1359886, Reg. Date : 05 May 2010, Immune Solutions Ltd.
13.
14. TB SCAN, U.S. Reg. No. 3,823,344, Reg.
Date: July 30, 2010,
15. LIPORALE, CTM Reg. No. 009080961, Reg.
Date: 27 September 2010, Immune Solutions Ltd.
16. BIOSPOT, U.S. Reg. No. 3,855,285, Reg.
Date: October 5, 2010, Cellular Technology Limited.
17. LIPORALE, NZ Reg. No. 823728, Reg.
Date: 5 November 2010, Immune Solutions Ltd.
18. UVSPOT, U.S. Reg. No. 3,871,787, Reg.
Date November 9, 2010, Cellular Technology Limited.
19. IMMUNOSPOT, CTM Reg. No. 006856769,
Reg. Date 11 November 2010, Cellular Technology Limited:
20. EPBMC, CTM Reg. No. 009225178, Reg.
Date 22 December 2010, Cellular Technology Ltd.
21. IMMUNOSPOT, U.S. Reg. No. 3,909,607.
Reg. Date:
January 25, 2011, Cellular Technology Ltd:
22.
23.
24. CXBLADDER, U.S. Reg. No. 4,188,826,
Reg. Date: 14 August 2012.
25. APOLLO, U.S. Reg. No. 4,574,930, Reg.
Date: July 29, 2014, Apollo Future Technology, Inc.
26. MBDXA, U.S. Reg. No. 4,585,240, Reg.
Date: August 12, 2014, MSACL, Inc.
27. Miscellaneous Design (Shore, River and
Mountains), U.S. Reg. No. 4,608,560, Reg. Date: 23 September
2014.
28. PACIFIC EDGE, U.S. Reg. No. 4,662,781,
Reg. Date: 30 December 2014.
SELECTED SCIENTIFIC
PUBLICATIONS
Peer-Reviewed
Articles
1.
Borson DB, Chinn RA, Davis B, Nadel JA. Adrenergic and cholinergic nerves mediate
fluid secretion from tracheal glands of ferrets. J Appl Physiol
49:1027-1031, 1980.
2.
Borson DB, Charlin M, Gold BD, Nadel JA. Neural regulation of
35SO4-macromolecule
secretion from tracheal glands of ferrets. J Appl Physiol 57:457-466, 1984.
3.
Gashi AA, Borson DB, Finkbeiner WE, Nadel JA, Basbaum CB. Neuropeptides degranulate serous cells of ferret tracheal glands. Am J Physiol
251(Cell Physiol 20):C223-C229,
1986.
4.
Borson DB, Corrales R, Varsano S, Gold M, Viro N, Caughey G, Ramachandran J,
Nadel JA.
Enkephalinase inhibitors potentiate substance P-induced
secretion of 35SO4-macromolecules from ferret trachea. Exp Lung Res 12:21-36,
1987.
5.
Caughey GH, Viro NF,
Ramachandran J, Lazarus SC, Borson DB, Nadel JA. Dog mastocytoma
tryptase: affinity purification, characterization and
amino-terminal sequence.
Arch Biochem Biophys 258:555-563,
1987.
6.
Sekizawa K, Tamaoki J, Nadel JA, Borson DB. Enkephalinase inhibitor
potentiates substance P- and electrically induced contraction in ferret
trachea. J Appl Physiol 63:1401-1405, 1987.
7.
Varsano S, Basbaum
CB, Forsberg LS, Borson DB, Caughey G, Nadel JA. Dog tracheal epithelial cells in culture
synthesize sulfated macromolecular glycoconjugates and
release them from the cell surface upon exposure to extracellular
proteinases. Exp Lung Res 13:157-183,
1987.
8.
Dusser DJ, Nadel JA,
Sekizawa K, Graf PD, Borson DB. Neutral endopeptidase and angiotensin converting enzyme inhibitors
potentiate kinin-induced contraction of ferret
trachea. J Pharm Exp Ther 244:531-536, 1988.
9.
Sheppard D, Thompson JE, Scypinski L, Dusser D, Nadel JA, Borson
DB. Toluene diisocyanate increases airway responsiveness to substance P
and decreases airway enkephalinase. J Clin
Invest 81:1111-1115, 1988.
10. Dusser DJ, Umeno E, Graf PD,
Borson DB, Nadel JA. Airway neutral endopeptidase-like enzyme modulates tachykinin-induced bronchoconstriction in vivo. J Appl
Physiol. 65:2585-2591, 1988.
11. Kohrogi H, Graf PD, Sekizawa K,
Borson DB, Nadel JA. Neutral endopeptidase inhibitors potentiate substance P- and
capsaicin-induced cough in awake guinea pigs.
J Clin Invest 82:2063-2068,
1988.
12.
Djokic TD, Sekizawa K, Borson DB, Nadel JA. Neutral endopeptidase inhibitors potentiate substance P-induced
contraction in gut smooth muscle. Am J Physiol 256:G39-G41, 1989.
13. Djokic TD, Nadel JA, Dusser DJ, Sekizawa K, Graf PD,
Borson DB. Inhibitors of neutral endopeptidase potentiate electrically and capsaicin-induced
noncholinergic contraction in guinea pig
bronchi. J Pharmacol Exp Ther 248:7-11,
1989.
14. Borson DB,
Brokaw JJ, Sekizawa K, McDonald DM, Nadel JA. Neutral endopeptidase and neurogenic inflammation in rats with
respiratory infections.
J Appl Physiol. 66:2653-2658,
1989.
15. Kohrogi H, Nadel JA, Malfroy B, Gorman C, Bridenbaugh
B, Patton JS, Borson DB. Recombinant human enkephalinase (neutral endopeptidase) prevents cough induced by tachykinins in awake guinea pigs. J Clin Invest 84:781-786,
1989.
16.
Dusser DJ, Djokic TD, Borson DB, Nadel JA. Cigarette
smoke induces bronchoconstrictor hyperresponsiviness to substance P and inactivates airway
neutral endopeptidase in the guinea
pig. J Clin
Invest, 84:900-906, 1989.
17.
Rubinstein I, Iwamoto I, Ueki IF, Borson DB, Nadel JA. Recombinant
neutral endopeptidase attenuates substance P-induced
plasma extravasation in the guinea pig skin. Int Arch Allergy and Appl Immunol. 91:232-238, 1990.
18. Borson DB,
19. Katayama M,
Nadel, J.A, Bunnett NW,
DiMaria, G.U, Haxhiu, M.A.,
Borson DB. Catabolism of calcitonin gene-related
peptide by neutral endopeptidase. Peptides 12:563-567,
1991.
20.
DiMaria GU, Katayama M, Borson DB, and Nadel JA. Neutral endopeptidase modulates endothelin-1-induced airway smooth
muscle contraction in guinea pig.
Regul. Peptides 39:137-145, 1992.
Review Articles, Books, and
Book Chapters
21. Borson, DB.
Neural regulation of secretion from tracheal submucosal glands.
Ph.D. Dissertation.
22.
Nadel JA, Borson DB, Basbaum DB, Widdicombe JH. Techniques for
studying airway mucus secretion, ion transport and water movement. In Techniques in the Life
Sciences. Techniques in Respiratory Physiology - Part
I. Otis AB, ed. Elsevier Scientific Publishers Ireland
Ltd.,
23. Nadel JA, Borson DB.
Secretion and ion transport in
airways during inflammation.
Biorheology
24:541-549, 1987.
24. Nadel JA, Borson DB.
Modulation of neuropeptide actions
by enkephalinase. In Pharmacology. Rand MJ,
Raper C, eds.
Elsevier Science Publishers B.V., pp: 425-439,
1987.
25. Nadel JA, Borson DB.
Modulation of tachykinins and bradykinin by
enkephalinase.
In Mechanisms in
Asthma: Pharmacology, Physiology,
and Management. Armour CL, Black JL, eds. Alan R. Liss, Inc.
26. Borson DB,
Gashi AA, Nadel JA. Methods for studying secretion from
airways. In: Methods in
Mucology.
27. Borson DB,
Nadel JA.
Regulation of airway
secretions. In Workshop on Rhinitis and Asthma;
Similarities and Differences.
Mygind N, Pipkorn U,
Dahl R, eds. Munksgaard, Copehnagen, Denmark, Chapter 6, pp:76-99,
1990.
28. Borson
DB. Roles of neutral endopeptidase in airways. Am. J. Physiol. 260 (Lung Cellular and
Molecular Physiol. 4:L212-L225, 1991.
29. Borson, DB,
Nadel, JA.
Neutral Endopeptidase as a Possible Therapeutic Drug. In: Advances in Asthmology 1990: Proceedings of the XIII International
Congress of Asthmology, held in
30. Borson,
DB. Possible Roles of Peptides and Peptidases in
Asthma. American
Abstracts
31.
Gamsu G, Borson B, Webb WR, Nadel JA. Structure:
function correlation in tracheal stenosis. Am Rev Respir
Dis 115:328, 1977.
32. Borson B,
Chinn R, Davis B, Nadel J. Electrical stimulation of cholinergic nerves
to submucosal glands in ferret trachea in
vitro. Physiologist 22:12,
1979.
33. Borson DB,
Nadel J.
Mucous secretory response of
canine tracheal pouch. Fed Proc
38:1330, 1979.
34. Borson DB,
Nadel JA.
Adrenergic neurotransmission to
tracheal submucosal glands of ferrets. Clin Res 29:98A,
1981.
35. Borson DB,
Nadel JA.
Cholinergic nerves inhibit
adrenergic neurotransmission to tracheal submucosal
glands of ferrets. Fed Proc 40:254, 1981.
36. Borson DB,
Charlin M, Gold BD, Nadel
JA. Nonadrenergic noncholinergic
nerves mediate secretion of macromolecules by tracheal glands of
ferrets. Fed Proc 41:1754, 1982.
37. Borson DB,
Caughey G,
38. Borson DB,
Corrales RJ, Viro N, Nadel
JA. Substance P (SP) regulation of
35SO4 macromolecule
secretion from ferret trachea. Am Rev Respir
Dis 131:A27, 1985.
39. Borson DB,
Gold M, Varsano S, Caughey
G, Ramachandran J, Nadel JA. Enkephalinase inhibitors potentiate tachykinin-induced release of
35SO4-labeled macromolecules from ferret trachea. Fed Proc
45:626, 1986.
40. Borson DB,
Malfroy B, Gold M, Ramachandran J, Nadel JA. Tachykinins inhibit enkephalinase activity from tracheas and lungs of
ferrets. Physiologist 29:174,
1986.
41.
Forsberg LS, Varsano S, Borson DB, Basbaum CB, Nadel JA. Keratinase-sensitive
cell surface glycans are synthesized by cultured
tracheal epithelial cells. Fed Proc 45:1904, 1986.
42.
Sekizawa K, Tamaoki J, Nadel JA, Borson DB. Enkephalinase inhibitor
(leucine-thiorphan) potentiates mammalian tachykinin-induced contraction in ferret
trachea. Fed Proc 46:650, 1987.
43.
Sheppard D, Thompson JE, Scypinski L, Dusser D, Nadel JA, Borson DB. Toluene diisocyanate increases airway responsiveness to substance P
and decreases airway enkephalinase. Physiologist 30:196, 1987.
44. Borson DB,
Brokaw J, Sekizawa K, McDonald D, Nadel JA. Viral infection increases permeability
response to substance P (SP) by decreasing tracheal neutral endopeptidase (NEP). FASEB J. 2:A1382,
1988.
45. Borson DB,
Brokaw J, Sekizawa K, McDonald D, Nadel JA. Viral infection increases tracheal
permeability response to substance P (SP) in rats by decreasing neutral endopeptidase (NEP). J Cell Biochem
[Suppl] 12B:295,
1988.
46. Nadel JA, Djokic TD, Djokic LT, Borson DB.
Neutral endopeptidase inhibitor potentiates neurotensin-induced contraction in guinea pig
bronchi. FASEB J. 2:A1383,
1988.
47.
Kohrogi H, Nadel JA, Malfroy B, Gorman C, Bridenbaugh B, Patton JS,
Borson DB. Recombinant
enkephalinase inhibits substance P- and
capsaicin-induced cough in awake guinea pigs. Am Rev Respir
Dis 139:A133, 1989.
48. Borson DB,
Jew S, Gruenert DC. Glucocorticoids increase expression of
neutral endopeptidase in transformed human tracheal
epithelial cells.
Physiologist 32:226,
1989.
49.
Katayama M, Bunnett NW, Ueki IF, Nadel JA, Borson DB. Recombinant
human neutral endopeptidase (NEP) cleaves calcitonin
gene-related peptide (CGRP). FASEB J. 4:A998,
1990.
50.
DiMaria GU, Katayama M, Graf PD, Borson DB, Nadel JA. Neutral endopeptidase modulates endothelin-induced contraction of guinea pig
trachea. Pharm. Res. 22 (Suppl2):170,
1990.
51. Borson DB,
52. Borson DB,
Katayama M. Calcitonin gene-related peptide inhibits
cleavage of substance P by recombinant human neutral endopeptidase.
FASEB J.5:A863,
1991.
53. Katayama M,
Nadel JA, Borson DB. Recombinant human neutral endopeptidase (NEP) cleaves human endothelin (ET1). FASEB J. 5:A863,
1991.
54. Borson DB,
Gies D, and C. Gorman. Transmembrane domain is necessary for expression of functional human
neutral endopeptidase. J. Cell. Biol. 115:61A, 1991.